CIBC World Market
BEAM icon

CIBC World Market’s Beam Therapeutics BEAM Stock Holding History

CIBC World Market’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,181
Closed -$277K – 1298
2023
Q4 		$277K Buy
10,181
+1,460
+17% +$36.3K ﹤0.01% 1088
2023
Q3 		$210K Buy
+8,721
New +$234K ﹤0.01% 1138

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

CIBC World Market's BEAM Position: Q1 2024 in Review

CIBC World Market sold out of Beam Therapeutics (BEAM) in Q1 2024, closing a stake of 10,181 shares — an estimated $277K sold.

CIBC World Market first reported a position in BEAM in Q3 2023 and held it in 2 quarters. The position peaked at $277K in Q4 2023. 221 funds tracked by Wall St. Rank hold BEAM as of Q1 2024.

  • CIBC World Market reported no remaining Beam Therapeutics position as of Q1 2024 after selling out during the quarter.
  • CIBC World Market sold 10,181 Beam Therapeutics shares in Q1 2024, an estimated $277K.
  • CIBC World Market first reported a position in Beam Therapeutics in Q3 2023 and held it in 2 quarters.
  • CIBC World Market's Beam Therapeutics position peaked at $277K in Q4 2023.
  • 221 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2024.

Based on CIBC World Market's 13F filing for Q1 2024, filed 13 May 2024.